World's Best Scientists 2026 revealed!

D-Index & Metrics

Biology and Biochemistry

D-Index
70
Citations
24642
World Ranking
6878
National Ranking
242

Overview

Aly Karsan is affiliated with the University of British Columbia in Canada. Their research primarily focuses on medicine, with significant contributions to biochemistry, genetics, and molecular biology.

The scientist's work spans several subfields, including molecular biology, hematology, genetics, cancer research, and pathology and forensic medicine. Their research topics cover various aspects such as cancer genomics and diagnostics, acute myeloid leukemia research, genetic factors in colorectal cancer, lymphoma diagnosis and treatment, BRCA gene mutations in cancer, lung cancer treatments and mutations, and chronic lymphocytic leukemia research.

Among their recent publications are:

  • SF3B1-mutant MDS as a distinct disease subtype: a proposal from the International Working Group for the Prognosis of MDS, 2020, Blood
  • Evaluating the quantity, quality and size distribution of cell-free DNA by multiplex droplet digital PCR, 2020, Scientific Reports
  • A clinical transcriptome approach to patient stratification and therapy selection in acute myeloid leukemia, 2021, Nature Communications
  • Computational pathology in 2030: a Delphi study forecasting the role of AI in pathology within the next decade, 2023, EBioMedicine
  • Colorectal Cancer Detection Based on Deep Learning, 2020, Journal of Pathology Informatics

Karsan frequently publishes in the following venues:

  • Blood
  • bioRxiv (Cold Spring Harbor Laboratory)
  • Experimental Hematology
  • Nature Communications
  • Journal of Clinical Oncology

The scientist has collaborated regularly with several coauthors, including:

  • Dean A. Regier
  • Kasmintan A. Schrader
  • Jeremy Parker
  • Ian Bosdet
  • Marco A. Marra

Best Publications

  • Genomic and epigenomic landscapes of adult de novo acute myeloid leukemia

    Timothy J. Ley;Christopher Miller;Li Ding;Benjamin J. Raphael

  • Apoptotic vascular endothelial cells become procoagulant

    Thomas Bombeli;Aly Karsan;Jonathan F. Tait;John M. Harlan

  • Identification of miR-145 and miR-146a as mediators of the 5q– syndrome phenotype

    Daniel T Starczynowski;Florian Kuchenbauer;Bob Argiropoulos;Sandy Sung

  • Lipopolysaccharide signaling in endothelial cells

    Shauna M Dauphinee;Aly Karsan

  • Recent insights into the role of Notch signaling in tumorigenesis

    Kevin G. Leong;Aly Karsan

  • Jagged1-mediated Notch activation induces epithelial-to-mesenchymal transition through Slug-induced repression of E-cadherin

    Kevin G. Leong;Kyle Niessen;Iva Kulic;Afshin Raouf

  • Slug is a direct Notch target required for initiation of cardiac cushion cellularization

    Kyle Niessen;YangXin Fu;YangXin Fu;Linda Chang;Pamela A. Hoodless;Pamela A. Hoodless

  • Notch Activation Results in Phenotypic and Functional Changes Consistent With Endothelial-to-Mesenchymal Transformation

    Michela Noseda;Graeme McLean;Kyle Niessen;Linda Chang

  • Concurrent CIC mutations, IDH mutations, and 1p/19q loss distinguish oligodendrogliomas from other cancers.

    Stephen Yip;Yaron S. Butterfield;Olena Morozova;Suganthi Chittaranjan

  • Notch Signaling in Cardiac Development

    Kyle Niessen;Aly Karsan

  • ENDOTHELIAL CELL DEATH INDUCED BY TUMOR NECROSIS FACTOR-ALPHA IS INHIBITED BY THE BCL-2 FAMILY MEMBER, A1

    Aly Karsan;Esther Yee;John M. Harlan

  • Notch Activation Induces Endothelial Cell Cycle Arrest and Participates in Contact Inhibition: Role of p21Cip1 Repression

    Michela Noseda;Linda Chang;Graeme McLean;Jonathan E. Grim

  • Fibroblast growth factor-2 inhibits endothelial cell apoptosis by Bcl-2-dependent and independent mechanisms.

    Aly Karsan;Esther Yee;Guy G. Poirier;Ping Zhou

  • TP53 mutation status divides myelodysplastic syndromes with complex karyotypes into distinct prognostic subgroups

    Detlef Haase;Kristen E Stevenson;Donna Neuberg;Jaroslaw P Maciejewski

  • SF3B1-mutant MDS as a distinct disease subtype: a proposal from the International Working Group for the Prognosis of MDS

    Luca Malcovati;Kristen Stevenson;Elli Papaemmanuil;Donna Neuberg

  • Cloning of human Bcl-2 homologue: inflammatory cytokines induce human A1 in cultured endothelial cells

    Aly Karsan;Esther Yee;Kenneth Kaushansky;John M. Harlan

  • Activated Notch4 Inhibits Angiogenesis: Role of β1-Integrin Activation

    Kevin G. Leong;Xiaolong Hu;Linheng Li;Michela Noseda

  • Alpha-1-antitrypsin and a broad spectrum metalloprotease inhibitor, RS113456, have similar acute anti-inflammatory effects.

    Andrew Churg;Jin Dai;Katalin Zay;Aly Karsan

  • Lipopolysaccharide induces the antiapoptotic molecules, A1 and A20, in microvascular endothelial cells.

    Xiaolong Hu;Xiaolong Hu;Esther Yee;Esther Yee;John M. Harlan;John M. Harlan;Fred Wong;Fred Wong

  • Smooth Muscle α-Actin Is a Direct Target of Notch/CSL

    Michela Noseda;YangXin Fu;Kyle Niessen;Fred Wong

Frequent Co-Authors

Marco A. Marra
Marco A. Marra University of British Columbia
Steven J.M. Jones
Steven J.M. Jones University of British Columbia
Pamela A. Hoodless
Pamela A. Hoodless University of British Columbia
Andrew J. Mungall
Andrew J. Mungall BC Cancer Agency
Wan L. Lam
Wan L. Lam BC Cancer Research Centre
Inanc Birol
Inanc Birol University of British Columbia
Martin Hirst
Martin Hirst University of British Columbia
Connie J. Eaves
Connie J. Eaves University of British Columbia
John M. Harlan
John M. Harlan University of Washington
Sean D. Young
Sean D. Young University of California, Irvine

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Best Scientists Citing Aly Karsan

Trending Scientists